Related Experiment Video
Updated: Jun 28, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Are randomised trials needed in the era of rapidly evolving technologies?
1Clinical Operational Research Unit, Department of Mathematics, UCL, London, United Kingdom. tom.treasure@gmail.com
Summary
New cardiothoracic treatments require demonstrated effectiveness and cost-effectiveness. Surgeons must prove value compared to existing therapies to justify adoption within healthcare budgets.
Area of Science:
- Cardiothoracic surgery
- Health economics
- Medical technology assessment
Background:
- Healthcare budgets face limitations, restricting the adoption of expensive new technologies.
- Introduction of novel treatments necessitates careful consideration of their impact on existing care pathways and future innovations.
- The integration of high-technology treatments requires justification beyond mere cost, focusing on demonstrable value.
Purpose of the Study:
- To emphasize the critical need for cardiothoracic surgeons to establish the efficacy of new treatments.
- To highlight the requirement for robust evidence of cost-effectiveness for novel cardiothoracic interventions.
- To advocate for a value-based approach in adopting advanced medical technologies in cardiothoracic surgery.
Main Methods:
- Comparative analysis of treatment outcomes.
- Health economic evaluations, including cost-effectiveness studies.
- Systematic review of clinical trial data and real-world evidence.
Main Results:
- Effectiveness of new treatments must be rigorously proven.
- Cost-effectiveness must be demonstrated in comparison to alternative therapies.
- Evidence-based justification is paramount for integrating new technologies.
Conclusions:
- Cardiothoracic surgeons must prioritize demonstrating treatment effectiveness.
- Evidence of cost-effectiveness is essential for the adoption of new high-technology treatments.
- A balanced approach integrating clinical efficacy and economic value is crucial for sustainable healthcare innovation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...